Circular Genomics Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Circular Genomics, based in San Diego, California, operates in the biotechnology research sector as a developer of circular RNA–based tools, data, and diagnostics for precision neurology and psychiatry. The company aims to enable earlier identification of brain-related diseases and to support personalized patient management through assays and associated data resources, focusing on conditions such as Alzheimer's disease, Parkinson's disease, major depressive disorder, and bipolar disorder. Its work relies on exclusive licenses and emerging circRNA technologies to inform clinical decision-making and risk stratification in brain health. Recent activity includes the July 2026 launch of CircPATH, announced after a Nature Medicine study showcased its potential for early Alzheimer's detection. In 2026 the company announced strategic collaborations with the Global Alzheimer's Platform Foundation and with Decode Health and Vitazi.ai to support research and validation in early neurological and psychiatric detection.
1-888-653-2347 
support@leadiq.com 
